Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
29th Dec 17 Source: Company
- €3.3 billion turnover
-
-€135 million
profit - 4,089 employees
-
30th Sep 16 Source: CRO
- €3.1 billion turnover
-
€276.9 million
profit - 5,112 employees
- 1 more year available »
Ranking
By Turnover
(€3.3 billion)- 29th in Top Companies
By Employees
(4,089)- 43rd in Top Companies
- 4,089
- €3.3 billion
Employees
- David Keenan Vice President}
Latest News
- 7:00am Warning that GDPR will lead to a surge in insurance claims
- 6:30am Arytza stock plunges, Macquarie plans expansion and Smurfit makes €460m move
- 6:02am Digiweb founder looks to cash in on data centre demand in US
- 5:50am Australian investment bank Macquarie set to expand Irish operation
- 5:30am Aryzta hits record low as profit warning stokes bank covenants fears